
Gene Therapy Slows Huntington’s Progression 75% — Including Dementia
For the first time, a one-time treatment has shown the ability to slow Huntington’s decline — including dementia symptoms — over three years.

For the first time, a one-time treatment has shown the ability to slow Huntington’s decline — including dementia symptoms — over three years.

J147 is a derivative of curry’s turmeric spice. It beat the Alzheimer’s drug Aricept (generic: donepezil) on several memory tests. The Salk Institute says it may benefit Parkinson’s, Huntington’s & vascular dementia.

Triheptanoin is available as a supplement or by prescription. A series of studies suggest it improves brain energy metabolism for people with Huntington’s disease. Learn how.

Researchers have been able to mobilize the brain’s native stem cells to replenish a type of neuron lost in Huntington’s disease. Learn how they improved health and extended life in the lab.

Geneticists have discovered a promising direction in Huntington’s treatment. In the lab, glutathione peroxidase improved Huntington’s disease. Drugs mimicking this activity are already approved for

DRUG NEWS: Genentech will showcase the breadth and promise of their Neuroscience Portfolio at the 2019 American Academy of Neurology Annual Meeting. It includes new

As research continues, cures for dementias such as Huntington’s are within our grasp. Your support can help make the next discovery possible.

Researchers discovered how genetic mutations in Huntington’s disease kill brain cells. Learn why this discovery may be relevant to other types of dementia, as well.

New research shows that the Alzheimer’s drug memantine (Namenda™) may treat Huntington’s dementia. It seems to improve motor learning and coordination, as well as keep cells alive. It appears to work in a way that could also benefit dementia in traumatic brain injury and some forms of stroke. Can memantine offer a multi-type dementia breakthrough?

A new test that can be completed in less than three minutes enables simple, accurate detection of cognitive impairment and Alzheimer’s in cognitively normal adults, including those with no symptoms of dementia. Find out more.

Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.

A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.

A new test that can be completed in less than three minutes enables simple, accurate detection of cognitive impairment and Alzheimer’s in cognitively normal adults, including those with no symptoms of dementia. Find out more.

Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.

A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.

Here’s a good activity caregivers can use easily, contributed by one of our readers. It’s a simple game, great in mid-stage Alzheimer’s.
No spam, only news and updates.


